CordCell

CordCell is a leading Brazilian biotechnology company specializing in the cryopreservation and therapeutic application of stem cells derived from umbilical cord blood, umbilical cord tissue, and dental pulp. Founded in 2004 and based in São Paulo, the company operates a high-tech laboratory and storage facility that adheres to international quality standards, including AABB accreditation. Beyond its core business of biological insurance and storage, CordCell is actively engaged in clinical research and the development of advanced cell therapies for conditions such as Type 1 Diabetes and Cerebral Palsy. The company serves as a critical hub for regenerative medicine in Latin America, providing both clinical services and research infrastructure. Its mission focuses on leveraging the potential of mesenchymal and hematopoietic stem cells to provide innovative treatment options for complex diseases.